Doxorubicin prodrug-based nanomedicines for the treatment of cancer

文献类型： 外文期刊

第一作者： Zhao, Haibo

作者： Zhao, Haibo;Zhang, Renshuai;Jiang, Hongfei;Yu, Jing;Chen, Pengwei;Yu, Wanpeng

作者机构：

关键词： Doxorubicin; Prodrug; Nanomedicine; Stimuli responsive; Cancer therapy; Antitumor

期刊名称：EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY （ 影响因子：6.7； 五年影响因子：6.5 ）

ISSN： 0223-5234

年卷期： 2023 年 258 卷

页码：

收录情况： SCI

摘要： The chemotherapeutic drug of doxorubicin (DOX) has witnessed widespread applications for treating various cancers. DOX-treated dying cells bear cellular modifications which allow enhanced presentation of tumor antigen and neighboring dendritic cell activation. Furthermore, DOX also facilitate the immune-mediated clearance of tumor cells. However, disadvantages such as severe off-target toxicity, and prominent hydrophobicity have resulted in unsatisfactory clinical therapeutic outcomes. The effective delivery of DOX drug molecules is still challenging despite the rapid advances in nanotechnology and biomaterials. Huge progress has been witnessed in DOX nanoprodrugs owing to their brilliant benefits such as tumor stimuli-responsive drug release capacity, high drug loading efficiency and so on. This review summarized recent progresses of DOX prodrug-based nanomedicines to provide deep insights into future development and inspire researchers to explore DOX nanoprodrugs with real clinical applications.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序